Heather Preston is Director at Karuna Therapeutics, Inc. (KRTX). They have made 8 open-market trades across 4 companies since 2018, most recently 2022-11-30.
CIK 0001606826
8 open-market purchases totalling $10.7M since 2018, never a sale. Across 8 scored buys the stock is down 3.6% at ninety days, and 0.2 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 63% | 50% | 38% |
| Avg Move | +11.8% | +4.6% | -3.6% |
| Alpha | +12.8% | +2.8% | -0.2% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KRTX | BUY | 2020-09-04 | 2020-09-09 | $72.36 | $25K | +6.4% | +5.6% | +33.0% |
| FUSN | BUY | 2020-06-30 | 2020-07-02 | $17.00 | $150K | -1.9% | -20.1% | -27.1% |
| AKUS | BUY | 2020-06-30 | 2020-07-02 | $17.00 | $5.1M | +1.6% | -4.8% | +7.1% |
| KRTX | BUY | 2020-03-10 | 2020-03-12 | $74.43 | $227K | -3.9% | -8.6% | +33.3% |
| KRTX | BUY | 2020-01-09 | 2020-01-10 | $70.50 | $56K | +36.8% | +32.6% | -6.3% |
| KRTX | BUY | 2020-01-03 | 2020-01-07 | $69.80 | $100K | +46.1% | +33.0% | -2.4% |
| KRTX | BUY | 2019-12-31 | 2020-01-03 | $70.00 | $13K | +20.2% | +30.8% | -8.5% |
| ETTX | BUY | 2018-09-28 | 2018-10-02 | $15.00 | $5.1M | -10.6% | -32.0% | -58.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.